Weak electrical pulses can stop certain life-threatening arrhythmias, study shows

Atrial and ventricular fibrillations are dangerous heart arrhythmias that claim millions of lives each year. Current treatment for them is a high-energy defibrillation shock that can be intensely painful and lead to further heart damage. New work applying principles from nonlinear dynamics looks to find ways to reset the heart with fewer side effects.

With numerical simulations, researchers from the Max Planck Institute for Dynamics and Self-Organization, German Center for Cardiovascular Research, Georg-August-Universitӓt Gӧttingen, and University Medical Center Gӧttingen have demonstrated a new way to time weak electrical pulses that can stop certain life-threatening arrhythmias. Publishing their work in Chaos, by AIP Publishing, the group shows that timed pulses are successful in ending atrial and ventricular fibrillations.

The study provides early evidence that one theorized approach to controlling fibrillations – adaptive deceleration pacing – can improve the performance of defibrillators.

In numerical simulations, we investigate how the dynamics of chaotic electrical excitation waves, which govern the dynamics of the heart during fibrillations, can be controlled more efficiently. Our goal is to use numerical simulations to find control strategies that avoid the application of high-energy shocks and that can also be tested in experimental setups and eventually on patients to reduce side effects."

Thomas Lilienkamp, Author

Adaptive deceleration pacing uses a series of weak pulses that are spaced farther apart over time to respond to the heart and return it to a normal rhythm in a few beats.

"With our approach, we can develop a pulse sequence specifically designed for a specific patient and even for a specific arrhythmia," Lilienkamp said. "This can be crucial, since even two arrhythmias in the same patient can be different in terms of the underlying dynamics characterized."

After starting a chaotic spiral wave form that is characteristic of the arrhythmias in four different heart models, the authors tested their approach using different pulse pacing sequences. The high-dimensional complexity of the dynamics and its dependence on control parameters makes numerical simulations a useful tool for handling such a high volume of calculations.

"In order to investigate and compare the performance of different pulse sequences, a large number of numerical simulations is required. The success rate we use as a benchmark for a specific pulse sequence is a statistical quantity averaged over the result of many single simulations," Lilienkamp said.

Adapting the rate of deceleration to the spectrum of electrical signal frequencies in the simulated cardiac tissue significantly increased the success rate of stopping arrhythmias with relatively weak pulses. To boot, the adaptive deceleration pacing doesn't require a sophisticated set of control parameters, showing promise for use in future defibrillators.

The group hopes to continue its work in more complex models and in experimental setups with real cardiac tissue.

Source:
Journal reference:

Lilienkamp, T., et al. (2022) Taming cardiac arrhythmias: Terminating spiral wave chaos by adaptive deceleration pacing. Chaos An Interdisciplinary Journal of Nonlinear Science. doi.org/10.1063/5.0126682.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New nasal spray form of bumetanide shows promise for heart failure treatment